PACS

Value Q4, 25Q1, 26Q2, 26 TTM Total revenue 1.36 B1.42 B1.43 B 5.55 B Gross profit 303.84 M327.88 M318.34 M 1.23 B Operating expenses 209.15 M207.85 M115.65 M 730.28 M Selling/general/admin expenses 116.3 M112.31 M114.31 M 449.18 M Research & development ——— — Operating income 94.69 M120.03 M109.33 M 410.32 M Non-Operating Income, Total -7.88 M-6.3 M-3.49 M -27.64 M Interest expense, net of interest capitalized 8.58 M6.42 M6.04 M 29.57 M Non-Operating Income, excl. Interest Expenses -16.45 M-12.85 M-12.08 M -59.88 M Unusual income/expense —125 K2.55 M — Pretax income 86.81 M113.74 M105.84 M 382.68 M Equity in earnings -949 K455 K730 K 724 K Taxes 27.03 M33.07 M29.49 M 113.55 M Non-controlling/minority interest 83 K-27 K-21 K -41 K After tax other income/expense ——— — Net income before discontinued operations 59.7 M80.69 M76.37 M 269.17 M Discontinued operations ——— — Net income 59.7 M80.69 M76.37 M 269.17 M Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 59.7 M80.69 M76.37 M 269.17 M Basic earnings per share (Basic EPS) 0.390.510.48 1.71 Diluted earnings per share (Diluted EPS) 0.420.50.47 1.71 Average basic shares outstanding 156.18 M157.07 M158.11 M — Diluted shares outstanding 156.7 M162.08 M161.99 M — EBITDA 96.83 M122.17 M111.46 M 419.16 M EBIT 94.69 M120.03 M109.33 M 410.32 M Cost of revenue 1.05 B1.09 B1.11 B 4.32 B Other cost of goods sold 1.04 B1.07 B1.09 B 4.25 B Depreciation & amortization (cash flow) 2.14 M2.13 M2.13 M 8.84 M